EXHIBITING AT MEDICAL CONFERENCES
Hepatologists, gastroenterologists and internists: HEPATIQ may be used to assess liver functional reserve for abnormal liver patients (>F0) .
Oncologists, interventionists and liver surgeons: HEPATIQ may be used to assess liver functional reserve before an intervention or surgery.
Please visit our booth at the following conferences to learn more about HEPATIQ and have your questions answered.
- Global Hepatitis Summit (GHS), Mar 18-20, Los Angeles, Booth G3.
- Society of Interventional Radiology (SIR), Mar 29-Apr 2, Nashville, Booth 324.
- Digestive Disease Week (DDW), May 4-6, San Diego, Booth 1511.
- Society for Nuclear Medicine and Molecular Imaging (SNMMI), Jun 21-24, New Orleans, Booth 1642.
- Health Connect Partners (HCP) Radiology & Imaging Online Reverse Expo, Jul 22-24.
- American Society for Radiation Oncology (ASTRO), Sep 28-30, San Francisco, Booth 208.
- American College of Gastroenterology (ACG) Oct 26-28, Phoenix.
- American Association for the Study of Liver Disease (AASLD), Nov 8-10, Washington DC, Booth 312.
- Radiological Society of North America (RSNA), Nov 30-Dec 3, Chicago, Booth 6804.
- Society of Interventional Oncology (SIO), Feb 4-8, 2026, Savannah, Georgia.
Free Trial
For a 3 month free trial of HEPATIQ (maximum of 30 patients), please submit: